Incidence of Dyschromatopsia in Glaucoma

University of Zurich100 enrolled

Overview

Incidence of dyschromatopsia

Incidence of dyschromatopsia should be elevated in glaucoma compared to a healthy control population. However, the actual incidence rate is not investigated.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Glaucoma

Interventions

Color Vision TestPROCEDURE

Farnsworth Panel D15/Hue test plus Ishihara charts

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * diagnosis of glaucoma * age between 18 and 99 years old * best corrected visual acuity(BCVA) \> 0.2 (decimal Snellen) Exclusion Criteria: * age \< 18 yo * BCVA \< 0.2 * known dyschromatopsia * known corneal disease * St.p. corneal surgeries * macula disease * history of medication use that can influence color vision (e.g. hydroxychloroquine)

Outcomes

Primary Outcomes

Incidence of dyschromatopsia

Incidence of dyschromatopsia should be elevated in glaucoma compared to a healthy control population. However, the actual incidence rate is not investigated.

Time frame: first and only study visit (day 1 of the study)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.